1. Carter, S. K., Newman, J. W., Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitro-sourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU) ? Clinical brochure. Cancer Chemother. Rep. Part 3, Vol.1, No. 1 (1968), 115?151.
2. Cheng, C. J., Fujimura, S., Grunberger, D., Weinstein, I. B., Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteinsin vivo andin vitro. Cancer Res.32 (1972), 22?27.
3. Druckrey, H., Ivankovic, S., Preussmann, R., Selektive Erzeugung maligner Tumoren im Gehirn und Rückenmark von Ratten durch N-methyl-N-nitrosoharnstoff. Z. Krebsforsch.66 (1965), 389?408.
4. Fewer, D., Wilson, C. B., Boldrey, E. B., Enot, J. K., Phase II study of CCNU (NSC-79037) in the treatment of brain tumours. Cancer Chemother. Rep.56 (1972), 421?427.
5. Gutin, P. H., Wilson, C. B., Kumar, A. R. V., Boldrey, E. B., Levin, V., Powell, M., Enot, K. J., Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumours. Cancer35 (1975), 1398?1404.